Mercator MedSystems Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
2ndary - Private
- Investors
-
12
Mercator MedSystems General Information
Description
Operator of a medical technology company intended to treat peripheral artery disease in patients. The company uses catheter-guided micro-infusion systems for site-specific non-systemic delivery of therapeutic agents directly across any blood vessel by safely delivering targeted therapeutic agents locally instead of systemically, enabling physicians to improve patient outcomes for vascular diseases, oncology, and regenerative medicines.
Contact Information
Website
www.mercatormed.comCorporate Office
- 520 McCormick Street
- San Leandro, CA 94577
- United States
Corporate Office
- 520 McCormick Street
- San Leandro, CA 94577
- United States
Mercator MedSystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 21. Secondary Transaction - Private | 29-Nov-2022 | Completed | Generating Revenue | |||
| 20. Grant | 20-Sep-2021 | Completed | Generating Revenue | |||
| 19. Later Stage VC (Series A2) | 04-Mar-2021 | Completed | Generating Revenue | |||
| 18. Later Stage VC | Completed | Generating Revenue | ||||
| 17. Debt - PPP | 13-Apr-2020 | Completed | Generating Revenue | |||
| 16. Later Stage VC (Series D) | 13-Jun-2019 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series C) | 18-Jul-2017 | Completed | Generating Revenue | |||
| 14. Later Stage VC (Series B1) | 20-Aug-2015 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series B) | 05-May-2014 | $19M | $28.1M | Completed | Generating Revenue | |
| 12. Grant | 01-Jan-2013 | $2.05M | $9.1M | Completed | Generating Revenue |
Mercator MedSystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 2 | ||||||||
| Series 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mercator MedSystems Comparisons
Industry
Financing
Details
Mercator MedSystems Competitors (12)
One of Mercator MedSystems’s 12 competitors is Arsenal Medical, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arsenal Medical | Venture Capital-Backed | Waltham, MA | ||||
| Neotherix | Accelerator/Incubator Backed | York, United Kingdom | ||||
| Wallaby Medical | Venture Capital-Backed | Shanghai, China | ||||
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
| FLEX Vascular | Venture Capital-Backed | Plymouth, MN |
Mercator MedSystems Patents
Mercator MedSystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021352423-A1 | Perivascular anti-inflammatory therapy for venous thrombosis | Inactive | 01-Oct-2020 | ||
| EP-4221715-A1 | Perivascular anti-inflammatory therapy for venous thrombosis | Pending | 01-Oct-2020 | ||
| EP-4221715-A4 | Perivascular anti-inflammatory therapy for venous thrombosis | Pending | 01-Oct-2020 | ||
| US-20220105108-A1 | Perivascular anti-inflammatory therapy for venous thrombosis | Pending | 01-Oct-2020 | ||
| WO-2022072698-A1 | Perivascular anti-inflammatory therapy for venous thrombosis | Inactive | 01-Oct-2020 | A61P7/04 |
Mercator MedSystems Signals
Mercator MedSystems Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| M&L Group | Venture Capital | Minority | ||
| Shenzhen Salubris Pharmaceuticals | Corporation | Minority | ||
| Aphelion Capital | Venture Capital | Minority | ||
| Medvest Capital | Venture Capital | Minority | ||
| SET Technology | Other | Minority |
Mercator MedSystems Investments (2)
Mercator MedSystems’s most recent deal was a Later Stage VC with Clarity Medical Systems for . The deal was made on 01-Jan-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Clarity Medical Systems | 01-Jan-2005 | Later Stage VC | Other Devices and Supplies | ||
| Clarity Medical Systems | 01-Jan-2003 | Later Stage VC | Other Devices and Supplies |
Mercator MedSystems FAQs
-
When was Mercator MedSystems founded?
Mercator MedSystems was founded in 2000.
-
Where is Mercator MedSystems headquartered?
Mercator MedSystems is headquartered in San Leandro, CA.
-
What is the size of Mercator MedSystems?
Mercator MedSystems has 17 total employees.
-
What industry is Mercator MedSystems in?
Mercator MedSystems’s primary industry is Drug Delivery.
-
Is Mercator MedSystems a private or public company?
Mercator MedSystems is a Private company.
-
What is Mercator MedSystems’s current revenue?
The current revenue for Mercator MedSystems is .
-
How much funding has Mercator MedSystems raised over time?
Mercator MedSystems has raised $71.5M.
-
Who are Mercator MedSystems’s investors?
M&L Group, Shenzhen Salubris Pharmaceuticals, Aphelion Capital, Medvest Capital, and SET Technology are 5 of 12 investors who have invested in Mercator MedSystems.
-
Who are Mercator MedSystems’s competitors?
Arsenal Medical, Neotherix, Wallaby Medical, ShockWave Medical, and FLEX Vascular are some of the 12 competitors of Mercator MedSystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process